WO1992006741A2 - Inhibition of restenosis by ultraviolet radiation - Google Patents
Inhibition of restenosis by ultraviolet radiation Download PDFInfo
- Publication number
- WO1992006741A2 WO1992006741A2 PCT/US1991/006313 US9106313W WO9206741A2 WO 1992006741 A2 WO1992006741 A2 WO 1992006741A2 US 9106313 W US9106313 W US 9106313W WO 9206741 A2 WO9206741 A2 WO 9206741A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- laser
- radiation
- angioplasty
- catheter
- restenosis
- Prior art date
Links
- 230000005855 radiation Effects 0.000 title claims abstract description 70
- 208000037803 restenosis Diseases 0.000 title claims abstract description 36
- 230000005764 inhibitory process Effects 0.000 title description 2
- 238000002399 angioplasty Methods 0.000 claims abstract description 42
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims abstract description 26
- 239000013307 optical fiber Substances 0.000 claims abstract description 21
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 19
- 230000004663 cell proliferation Effects 0.000 claims abstract description 6
- 230000003287 optical effect Effects 0.000 claims description 15
- 239000000835 fiber Substances 0.000 claims description 11
- 239000013078 crystal Substances 0.000 claims description 8
- 238000002647 laser therapy Methods 0.000 claims description 4
- 229910052779 Neodymium Inorganic materials 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 230000001678 irradiating effect Effects 0.000 claims description 2
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims 3
- 230000037431 insertion Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 230000001902 propagating effect Effects 0.000 claims 1
- 230000006378 damage Effects 0.000 abstract description 11
- 230000035755 proliferation Effects 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 description 14
- 238000000034 method Methods 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 6
- 238000013147 laser angioplasty Methods 0.000 description 6
- 230000003902 lesion Effects 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000001427 coherent effect Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 210000003038 endothelium Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 238000006303 photolysis reaction Methods 0.000 description 2
- 238000009117 preventive therapy Methods 0.000 description 2
- 239000010979 ruby Substances 0.000 description 2
- 229910001750 ruby Inorganic materials 0.000 description 2
- -1 Argon ion Chemical class 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- STZHXTXSRUJMJE-UHFFFAOYSA-N [Ba].[B]=O Chemical compound [Ba].[B]=O STZHXTXSRUJMJE-UHFFFAOYSA-N 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000002095 anti-migrative effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 210000003433 aortic smooth muscle cell Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000002839 fiber optic waveguide Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22001—Angioplasty, e.g. PCTA
- A61B2017/22002—Angioplasty, e.g. PCTA preventing restenosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
Definitions
- the technical field of this invention is surgical instruments and procedures and, in particular, systems and methods for inhibiting restenosis associated with angioplasty.
- Atherosclerosis is a disease which causes thickening and hardening of the arteries, characterized by lesions of raised fibrous plague formed within the arterial lumen.
- Atherosclerotic plaque is commonly treated by means of angioplasty through the use of a balloon catheter. Balloon angioplasty involves passing a small, balloon-tipped catheter percutaneously into an artery and up to the region of obstruction. The balloon is then inflated to dilate the area of obstruction.
- Other devices such as atherosclerectomy instruments which remove obstructions by dealing or shaving plaque from the artery wall, are also utilized in the treatment of atherosclerosis. More recently, laser systems have been proposed for performing angioplasty.
- Restenosis following angioplasty can be inhibited by reducing the proliferation of smooth muscle cells in the blood vessel walls at an angioplasty site, and such reduction in cell proliferation can be accomplished by irradiating the angioplasty site with the appropriate radiation in the ultraviolet (UV) wavelength range.
- the ultraviolet radiation is preferably delivered via an optical fiber or other waveguide incorporated, for example, into a percutaneous catheter. In operation, the ultraviolet radiation kills smooth muscle cells at the site, thereby reducing the risk of restenosis, while minimizing damage to surrounding tissue.
- UV radiation sources can be use in accordance with the present invention to deliver restenosis-preventive therapy, including both laser and non-coherent radiation sources.
- Either pulsed or continuous wave (“CW") lasers can be used, and the lasant medium can be gaseous, liquid or solid state.
- One preferred laser source is a pulsed excimer laser, such as a KrF laser.
- rare earth-doped solid state lasers, ruby lasers and NdrYAG lasers can be operated in conjunction with frequency modification means to produce an output beam at the appropriate UV wavelength.
- a UV flash lamp can be employed.
- the UV radiation source preferably produces an output beam having a wavelength less than about 280 nanometers.
- the invention can be practiced with a low energy radiation source.
- low energy is used herein to describe both laser and non-coherent radiation systems having an energy output of less than about 5 millijoules.
- high energy pulsed UV radiation source Usage of a high energy pulsed UV radiation source may be preferred for some applications.
- high energy is used herein to describe lasers which have an energy output of more than 5 millijoules or which generate peak powers on the order of 100 kilowatts per square centimeter or greater.
- At least one optical fiber for transmission of UV radiation is incorporated into a conventional balloon angioplasty device and operated to deliver therapeutical UV radiation to the angioplasty site either at the same time the balloon is inflated, or shortly before or after inflation.
- the balloon is first inflated to displace the vessel-obstructing plaque or lesion, and then the balloon is retracted to permit irradiation of the site by one or optical waveguides incorporated into the catheter.
- the balloon catheter has a diffusive tip through which the therapeutic UV laser radiation of the invention is delivered.
- At least one optical waveguide for transmission of UV radiation can be incorporated into an laser angioplasty device as an adjunct to the delivery of ablative laser radiation.
- a single catheter preferably can carry two bundles of optical fibers, one bundle serving to deliver ablative radiation (e.g., from a high energy, pulsed, excimer laser) and the other bundle carrying the UV radiation to kill a portion of the cells in the vicinity of the ablation site which would otherwise proliferate.
- the ablative and therapeutic radiation can be provided by two or more lasers operating in tandem, one laser source being used to deliver ablative laser radiation, and another laser source then employed to inhibit restenosis.
- separate optical waveguides can be used to deliver the ablative and therapeutic laser radiation, and two controllers are provided, one for each laser source, to allow them to operate independently.
- the ablative and therapeutic radiation can multiplexed and delivered via the same waveguide.
- the ablative laser radiation source can be any form of laser deemed appropriate for the particular application involved.
- a tunable laser delivering radiation at two or more wavelengths can be used and may be preferred for particular applications.
- a single wavelength of UV laser radiation can be generated, and such radiation can also be used to ablate the vessel-obstructing plaque or other lesion as well as reduce restenosis.
- UV radiation is transmitted through an optical waveguide to both perform angioplasty and kill smooth muscle cells at the angioplasty site.
- novel UV radiation sources are disclosed herein which overcome the problems of low transmissivity and low damage thresholds in fused silica or glass fibers by doping the fiber with a lasant such as Neodymium.
- the optical fiber is then pumped by energy from an optical pump source and acts as an amplifier to produce a full strength laser output beam at its distal end.
- High intensity pulsed radiation can be achieved by introducing a low power laser pulse into the proximal end of the fiber.
- Short wavelength visible and/or ultraviolet radiation can be obtained by disposing one or more frequency-modifying elements at the distal end of the instrument.
- a laser having an output beam wavelength of about 1064 nanometers such as a common Nd.YAG laser, can be used in conjunction with two doubling crystals to yield a radiation output of about 266 nanometers and an energy output of about 5-10 millijoules.
- a grouping of six to eight fibers delivering such radiation can be used to provide the laser power necessary for both ablation of plaque and treatment of the site to reduce the likelihood of restenosis.
- Novel catheter systems are also disclosed herein.
- Such catheter systems are useful in the performance of either balloon angioplasty or laser angioplasty and are preferably equipped with at least one optical waveguide for delivery of the UV radiation therapy, which can be, for example, an optical fiber having about a 200 micron diameter core.
- the catheter tip can also contain focusing optics or diffusive elements for use in directing the radiation emitted from the catheter within an artery.
- FIG. 1 is a schematic perspective view of a combined balloon and laser therapy catheter for performing angioplasty and reducing the likelihood of restenosis;
- FIG. 4 is a schematic perspective view of an alternative catheter for performing angioplasty and reducing the likelihood of restenosis
- FIGS. 6A-6C are schematic cross-sectional illustrations of a system incorporating the catheter of FIG. 4 in use to dilate a blood vessel and prevent restenosis;
- FIG. 7 is a schematic illustration of a laser device useful in the present invention. Detailed Description
- a combined balloon and laser therapy catheter 10 is shown, including inflatable balloon section 42 and a guide wire 14. Also disposed within the catheter are a plurality of optical fibers 54 for delivery of ultraviolet radiation.
- the catheter can also include a radio-opague tip 50.
- the distal end 12 of the catheter of FIG. 1 is shown in more detail, including an exemplary disposition of six optical fibers 54 about a central guide wire 14.
- FIGS. 3A-3C The use of the catheter system 10 is schematically illustrated in FIGS. 3A-3C.
- the guide wire 14 is first introduced into the obstructed blood vessel and used to guide the catheter 10 into position adjacent to the plaque or lesion (e.g., under radiographic control).
- the balloon section 42 is then inflated to form a balloon 44 which applies pressure against the obstruction 20, thereby dilating the obstructed region of the blood vessel 16.
- Inflation and deflation of the balloon 44 are controlled by a balloon controller 46.
- the balloon section 42 is deflated and retracted so that the distal tip of the catheter can be positioned to deliver UV radiation therapy to the angioplasty site 32.
- a therapeutical laser 28 can then be activated to deliver UV radiation 30 which will kill a major portion of the smooth muscle cells 40 within the media 24 of the blood vessel wall without damaging either the inner endothelium layer 22 or the outer adventitia 26 of the blood vessel.
- the end result of the operation is a substantially lessened obstruction with few, if any, smooth muscle cells remaining in the angioplasty site to proliferate and cause restenosis.
- an alternative catheter configuration 10A for performing both angioplasty and reducing the likelihood of stenosis including a guide wire 14 and two laser radiation delivery systems 76 and 78.
- the first laser delivery system 76 provides therapeutic UV radiation to inhibit restenosis.
- the second laser delivery system 78 operates to provide ablative laser radiation to remove obstructions in a blood vessel by photodecomposition.
- the catheter of FIG. 4 can also include a radio-opague tip 50 to aid in positioning the catheter within a blood vessel under radiographic control.
- the distal end of 12A of the catheter can include both the therapeutic UV radiation delivery system 76 and the ablative laser radiation delivery system 78.
- Multiple optical fibers 54 for UV radiation therapy are encased in a sleeve 66 which is positioned on one side of the guide wire to provide the UV therapy system.
- the catheter can further include a flushing port 72 for the introduction of saline at the site and/or a suction port 74 for clearing the site of fluids during laser operations.
- the optical waveguides 68 may be of any type appropriate to deliver the ablative laser radiation required for a particular application.
- the optical waveguide 68 can be optical fibers connected to an ablative radiation source such as a XeCl excimer laser operating in a pulsed mode at about 308 nanometers.
- the catheter can be withdrawn as shown in FIG. 6C, and few smooth muscle cells will remain within the area of the angioplasty injury. By killing a major portion of the smooth muscle cells, the risk of restenosis is again decreased.
- the therapeutic UV radiation can be provided by a variety of sources, including non-coherent UV light sources and excimer laser sources (e.g., a KrF excimer laser operating at 248 nanometers).
- an alternative laser device 70 which can be used in the present invention to provide the therapeutic UV radiation.
- an output beam from a laser source 48 such as Nd:YAG laser with an output radiation having a wavelength of about 1064 nanometers is introduced via coupler 56 into an optical fiber 54 which is preferably a rare earth-doped silica fiber (e.g. a Neodymium-doped optical fiber) .
- the fiber is also optically pumped by an optical pump source 52 (e.g., a laser diode having an output radiation wavelength of about 808 nanometers, likewise coupled to the fiber 54 by coupler 56).
- the doped optical fiber thus acts a laser amplifier.
- the system is terminated in two frequency-multiplying crystals 60 and 62.
- the first crystal 60 is a frequency-doubling optical element, such as a potassium dihydrogen phosphate (KDP) crystal
- the second crystal 62 is also a frequency-doubling optical element, such as a barium boron oxide (BBO) crystal.
- Focusing optics 64 such as a grated refractive index (“GRIN”) lens, can be included at the output end of the optical fiber 54.
- GRIN grated refractive index
- pulsed energy sources other than a NdrYAG laser.
- the pulsed laser medium can be gaseous, liquid or solid-state.
- Rare earth-doped solid state lasers, ruby lasers, alexandrite lasers, carbon dioxide lasers and excimer lasers are all examples of lasers that can be operated in pulsed mode and used as pulse-triggering elements in the present invention.
- the laser device 70 is particularly adapted for use within a catheter.
- a plurality of optical fibers of the type described herein can be used to provide the needed energy for performing either laser surgery or restenosis preventive therapy.
- the laser surgical systems of the present invention preferably have an output energy ranging from about 50 millijoules to about 100 millijoules.
- the systems can be operated at lower output energies, for example, from about 100 microjoules to about 10 millijoules. Other output energies can be employed as needed for particular applications.
- the number of delivery fibers can be varied to adjust the total system output.
- the laser device of Fig. 7 can be incorporated into other surgical tools, such as laser scalpels and/or endoscopes.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU85464/91A AU655939B2 (en) | 1990-10-10 | 1991-09-04 | Inhibition of restenosis by ultraviolet radiation |
JP3516153A JPH06501859A (en) | 1990-10-10 | 1991-09-04 | Suppression of restenosis by ultraviolet irradiation |
EP91917175A EP0552189B1 (en) | 1990-10-10 | 1991-09-04 | Inhibition of restenosis by ultraviolet radiation |
DE69108041T DE69108041T2 (en) | 1990-10-10 | 1991-09-04 | Inhibition of restenoses using UV radiation. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US595,033 | 1990-10-10 | ||
US07/595,033 US5053033A (en) | 1990-10-10 | 1990-10-10 | Inhibition of restenosis by ultraviolet radiation |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1992006741A2 true WO1992006741A2 (en) | 1992-04-30 |
WO1992006741A3 WO1992006741A3 (en) | 1992-08-20 |
Family
ID=24381438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/006313 WO1992006741A2 (en) | 1990-10-10 | 1991-09-04 | Inhibition of restenosis by ultraviolet radiation |
Country Status (9)
Country | Link |
---|---|
US (1) | US5053033A (en) |
EP (2) | EP0552189B1 (en) |
JP (1) | JPH06501859A (en) |
AT (2) | ATE168546T1 (en) |
AU (2) | AU655939B2 (en) |
CA (1) | CA2092537A1 (en) |
DE (2) | DE69108041T2 (en) |
ES (2) | ES2121592T3 (en) |
WO (1) | WO1992006741A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8109981B2 (en) | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
Families Citing this family (279)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992002276A1 (en) * | 1990-08-06 | 1992-02-20 | Acculase, Inc. | Fiber optic laser catheter and method of use |
US5354324A (en) * | 1990-10-18 | 1994-10-11 | The General Hospital Corporation | Laser induced platelet inhibition |
US6134003A (en) * | 1991-04-29 | 2000-10-17 | Massachusetts Institute Of Technology | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
US6111645A (en) | 1991-04-29 | 2000-08-29 | Massachusetts Institute Of Technology | Grating based phase control optical delay line |
US6501551B1 (en) | 1991-04-29 | 2002-12-31 | Massachusetts Institute Of Technology | Fiber optic imaging endoscope interferometer with at least one faraday rotator |
US6485413B1 (en) | 1991-04-29 | 2002-11-26 | The General Hospital Corporation | Methods and apparatus for forward-directed optical scanning instruments |
US5222949A (en) * | 1991-07-23 | 1993-06-29 | Intermed, Inc. | Flexible, noncollapsible catheter tube with hard and soft regions |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6190355B1 (en) * | 1992-01-10 | 2001-02-20 | Scimed Life Systems, Inc. | Heated perfusion balloon for reduction of restenosis |
US5830209A (en) * | 1992-02-05 | 1998-11-03 | Angeion Corporation | Multi-fiber laser catheter |
WO1993015676A1 (en) * | 1992-02-05 | 1993-08-19 | Angelase, Inc. | Laser catheter with movable integral fixation wire |
WO1994002077A2 (en) * | 1992-07-15 | 1994-02-03 | Angelase, Inc. | Ablation catheter system |
EP0597195B1 (en) * | 1992-08-18 | 1999-07-21 | The Spectranetics Corporation | Fiber optic guide wire |
US5770609A (en) * | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
US5383467A (en) * | 1992-11-18 | 1995-01-24 | Spectrascience, Inc. | Guidewire catheter and apparatus for diagnostic imaging |
US5439000A (en) * | 1992-11-18 | 1995-08-08 | Spectrascience, Inc. | Method of diagnosing tissue with guidewire |
US5417653A (en) * | 1993-01-21 | 1995-05-23 | Sahota; Harvinder | Method for minimizing restenosis |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5595722A (en) * | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
EP0696185B1 (en) | 1993-04-28 | 1998-08-12 | Focal, Inc. | Apparatus, product and use related to intraluminal photothermoforming |
ATE406909T1 (en) * | 1993-05-13 | 2008-09-15 | Poniard Pharmaceuticals Inc | PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMAL PROLIFERATION OF SMOOTH MUSCLE CELLS |
US5320617A (en) * | 1993-06-25 | 1994-06-14 | Leach Gary E | Method of laser-assisted prostatectomy and apparatus for carrying out the method |
DK0633041T3 (en) | 1993-07-01 | 2000-04-03 | Schneider Europ Gmbh | Medical apparatus for the treatment of blood vessels by means of ionizing radiation |
US5540659A (en) * | 1993-07-15 | 1996-07-30 | Teirstein; Paul S. | Irradiation catheter and method of use |
US6196996B1 (en) | 1993-07-15 | 2001-03-06 | Paul S. Teirstein | Irradiation catheter and method of use |
US5416878A (en) * | 1993-07-29 | 1995-05-16 | Endeavor Surgical Products, Inc. | Surgical methods and apparatus using a bent-tip side-firing laser fiber |
WO1995008289A2 (en) | 1993-09-16 | 1995-03-30 | Scimed Life Systems, Inc. | Percutaneous repair of cardiovascular anomalies and repair compositions |
US5470307A (en) * | 1994-03-16 | 1995-11-28 | Lindall; Arnold W. | Catheter system for controllably releasing a therapeutic agent at a remote tissue site |
EP0686342B1 (en) | 1994-06-10 | 1998-09-09 | Schneider (Europe) GmbH | A medical appliance for the treatment of a portion of body vessel by ionising radiation |
ATE196742T1 (en) | 1994-06-24 | 2000-10-15 | Schneider Europ Gmbh | MEDICINAL DEVICE FOR THE TREATMENT OF A PART OF A BODY VESSEL USING IONIZATION RADIATION |
US5637877A (en) * | 1995-06-06 | 1997-06-10 | Rare Earth Medical, Inc. | Ultraviolet sterilization of instrument lumens |
US5908415A (en) * | 1994-09-09 | 1999-06-01 | Rare Earth Medical, Inc. | Phototherapy methods and apparatus |
US6423055B1 (en) | 1999-07-14 | 2002-07-23 | Cardiofocus, Inc. | Phototherapeutic wave guide apparatus |
US8025661B2 (en) | 1994-09-09 | 2011-09-27 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US5632767A (en) * | 1994-09-09 | 1997-05-27 | Rare Earth Medical, Inc. | Loop diffusers for diffusion of optical radiation |
US5643253A (en) * | 1995-06-06 | 1997-07-01 | Rare Earth Medical, Inc. | Phototherapy apparatus with integral stopper device |
US5836940A (en) * | 1994-10-25 | 1998-11-17 | Latis, Inc. | Photoacoustic drug delivery |
US5817144A (en) * | 1994-10-25 | 1998-10-06 | Latis, Inc. | Method for contemporaneous application OF laser energy and localized pharmacologic therapy |
US5571151A (en) * | 1994-10-25 | 1996-11-05 | Gregory; Kenton W. | Method for contemporaneous application of laser energy and localized pharmacologic therapy |
US5899882A (en) * | 1994-10-27 | 1999-05-04 | Novoste Corporation | Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient |
US5683345A (en) | 1994-10-27 | 1997-11-04 | Novoste Corporation | Method and apparatus for treating a desired area in the vascular system of a patient |
US5665591A (en) * | 1994-12-06 | 1997-09-09 | Trustees Of Boston University | Regulation of smooth muscle cell proliferation |
DE4443964C1 (en) * | 1994-12-09 | 1996-04-04 | Schwarzmaier Hans Joachim Dr | Laser appts. for irradiation of human body tissue |
US5738676A (en) * | 1995-01-03 | 1998-04-14 | Hammer; Daniel X. | Laser surgical probe for use in intraocular surgery |
US5776174A (en) * | 1995-01-30 | 1998-07-07 | Illumenex Corporation | Stabilization of vascular lesions by ultraviolet radiation |
US5728090A (en) * | 1995-02-09 | 1998-03-17 | Quantum Devices, Inc. | Apparatus for irradiating living cells |
WO1996029943A1 (en) * | 1995-03-28 | 1996-10-03 | Eli Lilly And Company | Photodynamic therapy system and method |
US5620438A (en) * | 1995-04-20 | 1997-04-15 | Angiomedics Ii Incorporated | Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis |
US5607419A (en) * | 1995-04-24 | 1997-03-04 | Angiomedics Ii Inc. | Method and apparatus for treating vessel wall with UV radiation following angioplasty |
EP0833624B1 (en) | 1995-06-07 | 2007-11-07 | Poniard Pharmaceuticals, Inc. | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
US7611533B2 (en) | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US5840008A (en) * | 1995-11-13 | 1998-11-24 | Localmed, Inc. | Radiation emitting sleeve catheter and methods |
US6234951B1 (en) | 1996-02-29 | 2001-05-22 | Scimed Life Systems, Inc. | Intravascular radiation delivery system |
US5855546A (en) | 1996-02-29 | 1999-01-05 | Sci-Med Life Systems | Perfusion balloon and radioactive wire delivery system |
CA2248260C (en) | 1996-03-05 | 2010-11-16 | Michael D. Laufer | Vascular catheter-based system for heating tissue |
US5876426A (en) * | 1996-06-13 | 1999-03-02 | Scimed Life Systems, Inc. | System and method of providing a blood-free interface for intravascular light delivery |
US6443974B1 (en) | 1996-07-28 | 2002-09-03 | Biosense, Inc. | Electromagnetic cardiac biostimulation |
US5833682A (en) * | 1996-08-26 | 1998-11-10 | Illumenex Corporation | Light delivery system with blood flushing capability |
US5964751A (en) * | 1996-08-26 | 1999-10-12 | Illumenex Corporation | Light delivery system with blood flushing capability |
US6451044B1 (en) * | 1996-09-20 | 2002-09-17 | Board Of Regents, The University Of Texas System | Method and apparatus for heating inflammed tissue |
US6119031A (en) | 1996-11-21 | 2000-09-12 | Boston Scientific Corporation | Miniature spectrometer |
JP2001505100A (en) * | 1996-11-21 | 2001-04-17 | ボストン サイエンティフィック コーポレイション | Mucosal detachment using light |
US5775338A (en) * | 1997-01-10 | 1998-07-07 | Scimed Life Systems, Inc. | Heated perfusion balloon for reduction of restenosis |
EP1009467A4 (en) | 1997-02-19 | 2001-07-25 | Condado Med Devices Corp | Multi-purpose catheters, catheter systems, and radiation treatment |
CA2282546C (en) | 1997-03-04 | 2008-04-01 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency using directionally applied energy |
US6676590B1 (en) | 1997-03-06 | 2004-01-13 | Scimed Life Systems, Inc. | Catheter system having tubular radiation source |
US6309339B1 (en) | 1997-03-28 | 2001-10-30 | Endosonics Corporation | Intravascular radiation delivery device |
US6033357A (en) * | 1997-03-28 | 2000-03-07 | Navius Corporation | Intravascular radiation delivery device |
US6634363B1 (en) | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US7425212B1 (en) | 1998-06-10 | 2008-09-16 | Asthmatx, Inc. | Devices for modification of airways by transfer of energy |
US6200333B1 (en) | 1997-04-07 | 2001-03-13 | Broncus Technologies, Inc. | Bronchial stenter |
US6411852B1 (en) | 1997-04-07 | 2002-06-25 | Broncus Technologies, Inc. | Modification of airways by application of energy |
US6488673B1 (en) | 1997-04-07 | 2002-12-03 | Broncus Technologies, Inc. | Method of increasing gas exchange of a lung |
US6283988B1 (en) | 1997-04-07 | 2001-09-04 | Broncus Technologies, Inc. | Bronchial stenter having expandable electrodes |
US5972026A (en) | 1997-04-07 | 1999-10-26 | Broncus Technologies, Inc. | Bronchial stenter having diametrically adjustable electrodes |
US6273907B1 (en) | 1997-04-07 | 2001-08-14 | Broncus Technologies, Inc. | Bronchial stenter |
US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
DE19717790A1 (en) * | 1997-04-26 | 1998-10-29 | Convergenza Ag | Device with a therapeutic catheter |
US7048716B1 (en) * | 1997-05-15 | 2006-05-23 | Stanford University | MR-compatible devices |
US6200307B1 (en) | 1997-05-22 | 2001-03-13 | Illumenex Corporation | Treatment of in-stent restenosis using cytotoxic radiation |
US6019718A (en) | 1997-05-30 | 2000-02-01 | Scimed Life Systems, Inc. | Apparatus for intravascular radioactive treatment |
US6185443B1 (en) | 1997-09-29 | 2001-02-06 | Boston Scientific Corporation | Visible display for an interventional device |
US5984861A (en) | 1997-09-29 | 1999-11-16 | Boston Scientific Corporation | Endofluorescence imaging module for an endoscope |
US6096065A (en) | 1997-09-29 | 2000-08-01 | Boston Scientific Corporation | Sheath for tissue spectroscopy |
US6324418B1 (en) | 1997-09-29 | 2001-11-27 | Boston Scientific Corporation | Portable tissue spectroscopy apparatus and method |
US6238348B1 (en) | 1997-07-22 | 2001-05-29 | Scimed Life Systems, Inc. | Miniature spectrometer system and method |
WO1999004706A1 (en) * | 1997-07-28 | 1999-02-04 | Biosense Inc. | Reduction of restenosis |
US6200312B1 (en) | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
US5997571A (en) * | 1997-12-17 | 1999-12-07 | Cardiofocus, Inc. | Non-occluding phototherapy probe stabilizers |
US5855203A (en) * | 1997-12-19 | 1999-01-05 | Matter; Jean-Paul | Respiratory circuit with in vivo sterilization |
US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
US8181656B2 (en) | 1998-06-10 | 2012-05-22 | Asthmatx, Inc. | Methods for treating airways |
US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
US6106515A (en) * | 1998-08-13 | 2000-08-22 | Intraluminal Therapeutics, Inc. | Expandable laser catheter |
US6413203B1 (en) | 1998-09-16 | 2002-07-02 | Scimed Life Systems, Inc. | Method and apparatus for positioning radioactive fluids within a body lumen |
EP1157076A1 (en) | 1998-11-18 | 2001-11-28 | Radiovascular Systems, L.L.C. | Radioactive coating solutions, methods, and substrates |
US6398777B1 (en) | 1999-02-01 | 2002-06-04 | Luis Navarro | Endovascular laser device and treatment of varicose veins |
US9033961B2 (en) | 1999-07-14 | 2015-05-19 | Cardiofocus, Inc. | Cardiac ablation catheters for forming overlapping lesions |
US7935108B2 (en) | 1999-07-14 | 2011-05-03 | Cardiofocus, Inc. | Deflectable sheath catheters |
US8900219B2 (en) | 1999-07-14 | 2014-12-02 | Cardiofocus, Inc. | System and method for visualizing tissue during ablation procedures |
US8540704B2 (en) | 1999-07-14 | 2013-09-24 | Cardiofocus, Inc. | Guided cardiac ablation catheters |
US6445939B1 (en) | 1999-08-09 | 2002-09-03 | Lightlab Imaging, Llc | Ultra-small optical probes, imaging optics, and methods for using same |
US6352501B1 (en) | 1999-09-23 | 2002-03-05 | Scimed Life Systems, Inc. | Adjustable radiation source |
US6520981B1 (en) * | 1999-10-01 | 2003-02-18 | The General Hospital Corporation | Significance of dosimetry in photodynamic therapy of injured arteries |
US6398709B1 (en) | 1999-10-19 | 2002-06-04 | Scimed Life Systems, Inc. | Elongated member for intravascular delivery of radiation |
US6738661B1 (en) | 1999-10-22 | 2004-05-18 | Biosynergetics, Inc. | Apparatus and methods for the controllable modification of compound concentration in a tube |
US6470888B1 (en) | 1999-11-08 | 2002-10-29 | Freya, Llc | System for in vivo sterilization of a respiratory circuit |
US6416457B1 (en) | 2000-03-09 | 2002-07-09 | Scimed Life Systems, Inc. | System and method for intravascular ionizing tandem radiation therapy |
US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US20030153801A1 (en) * | 2001-05-29 | 2003-08-14 | Pharmacia Corporation | Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
US20030021694A1 (en) * | 2001-07-25 | 2003-01-30 | Yevin Oleg A. | Nano and micro metric dimensional systems and methods for nanopump based technology |
US6488628B1 (en) | 2001-07-31 | 2002-12-03 | Scimed Life Systems, Inc. | Method for ultrasonically profiling the distribution of an administered medicament |
US6908460B2 (en) | 2001-08-28 | 2005-06-21 | Joseph Distefano | Apparatus for conveying a light source to an intravenous needle to kill blood pathogens |
US6962584B1 (en) * | 2001-09-06 | 2005-11-08 | Stone Gregg W | Electromagnetic photonic catheter for reducing restenosis |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7201766B2 (en) | 2002-07-03 | 2007-04-10 | Life Support Technologies, Inc. | Methods and apparatus for light therapy |
WO2004012805A2 (en) | 2002-08-05 | 2004-02-12 | Miravant Medical Technologies | Light delivery catheter |
EP1526801A2 (en) * | 2002-08-05 | 2005-05-04 | Miravant Medical Technologies Inc. | Catheter for diagnosis and treatment of diseased vessels |
US7220778B2 (en) * | 2003-04-15 | 2007-05-22 | The General Hospital Corporation | Methods and devices for epithelial protection during photodynamic therapy |
US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
US20040236275A1 (en) * | 2003-05-20 | 2004-11-25 | Pruitt Sean R. | Catheter having a light emitting component |
US8251057B2 (en) | 2003-06-30 | 2012-08-28 | Life Support Technologies, Inc. | Hyperbaric chamber control and/or monitoring system and methods for using the same |
US20050027289A1 (en) * | 2003-07-31 | 2005-02-03 | Thomas Castellano | Cryoablation systems and methods |
US7291146B2 (en) | 2003-09-12 | 2007-11-06 | Minnow Medical, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US20050090722A1 (en) * | 2003-09-17 | 2005-04-28 | Thomas Perez | Method and apparatus for providing UV light to blood |
US7070594B2 (en) * | 2004-02-10 | 2006-07-04 | Cryocor, Inc. | System and method for assessing ice ball formation during a cryoablation procedure |
US7761945B2 (en) | 2004-05-28 | 2010-07-27 | Life Support Technologies, Inc. | Apparatus and methods for preventing pressure ulcers in bedfast patients |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
US20070093802A1 (en) * | 2005-10-21 | 2007-04-26 | Danek Christopher J | Energy delivery devices and methods |
US7382857B2 (en) * | 2004-12-10 | 2008-06-03 | Carl Zeiss Ag | X-ray catheter assembly |
US7159590B2 (en) * | 2004-12-20 | 2007-01-09 | Rife Robert W | Trachea tube with germicidal light source |
WO2006105121A2 (en) | 2005-03-28 | 2006-10-05 | Minnow Medical, Llc | Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues |
US20060235373A1 (en) * | 2005-04-14 | 2006-10-19 | Asah Medico A/S | Intraluminal heat treatment of a lumen combined with cooling of tissue proximate the lumen |
US20060293644A1 (en) * | 2005-06-21 | 2006-12-28 | Donald Umstadter | System and methods for laser-generated ionizing radiation |
JP4409499B2 (en) * | 2005-10-25 | 2010-02-03 | 国立大学法人浜松医科大学 | Thrombolysis device |
US8414568B2 (en) * | 2006-04-04 | 2013-04-09 | The Spectranetics Corporation | Laser-assisted guidewire having a variable stiffness shaft |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US8136531B2 (en) * | 2006-05-08 | 2012-03-20 | Chariff Mark D | Device and method for treating musculo-skeletal injury and pain by application of laser light therapy |
EP2954868A1 (en) | 2006-10-18 | 2015-12-16 | Vessix Vascular, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US7931647B2 (en) | 2006-10-20 | 2011-04-26 | Asthmatx, Inc. | Method of delivering energy to a lung airway using markers |
US20080234670A1 (en) * | 2007-03-15 | 2008-09-25 | Rogers C Brian | System and apparatus providing a controlled light source for medicinal applications |
US8622991B2 (en) | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
US9220837B2 (en) | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
CN104069567A (en) | 2007-03-19 | 2014-10-01 | 茵苏莱恩医药有限公司 | Drug delivery device |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
CN101795635B (en) | 2007-04-27 | 2012-06-06 | 泰科医疗集团有限合伙公司 | Systems and methods for treating hollow anatomical structures |
CA2724949A1 (en) * | 2007-06-27 | 2008-12-31 | The General Hospital Corporation | Method and apparatus for optical inhibition of photodynamic therapy |
US8235983B2 (en) | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
US8409133B2 (en) | 2007-12-18 | 2013-04-02 | Insuline Medical Ltd. | Drug delivery device with sensor for closed-loop operation |
US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
AU2009244058B2 (en) | 2008-05-09 | 2015-07-02 | Nuvaira, Inc | Systems, assemblies, and methods for treating a bronchial tree |
US8237081B2 (en) * | 2008-05-28 | 2012-08-07 | Caterpillar Inc. | Manufacturing system having delivery media and GRIN lens |
US8674259B2 (en) * | 2008-05-28 | 2014-03-18 | Caterpillar Inc. | Manufacturing system for producing reverse-tapered orifice |
US9770297B2 (en) | 2008-06-04 | 2017-09-26 | Covidien Lp | Energy devices and methods for treating hollow anatomical structures |
EP2355758A2 (en) | 2008-11-07 | 2011-08-17 | Insuline Medical Ltd. | Device and method for drug delivery |
JP5307900B2 (en) | 2008-11-17 | 2013-10-02 | べシックス・バスキュラー・インコーポレイテッド | Selective energy storage without knowledge of organizational topography |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
WO2011041629A2 (en) | 2009-10-02 | 2011-04-07 | Cardiofocus, Inc. | Cardiac ablation system with pulsed aiming light |
WO2011044248A2 (en) | 2009-10-06 | 2011-04-14 | Cardiofocus, Inc. | Cardiac ablation image analysis system and process |
WO2011056684A2 (en) | 2009-10-27 | 2011-05-12 | Innovative Pulmonary Solutions, Inc. | Delivery devices with coolable energy emitting assemblies |
AU2010319477A1 (en) | 2009-11-11 | 2012-05-24 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US20110130749A1 (en) * | 2009-11-27 | 2011-06-02 | Intermedic Arfran, S.A. | Method of endovenous laser treatment of varicose veins |
EP2555699B1 (en) | 2010-04-09 | 2019-04-03 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
CN101912306B (en) * | 2010-08-16 | 2012-09-05 | 郭从涛 | Device for rercutaneous interventional minimally-invasive treatment of tuberculosis focus in vivo |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US20120303011A1 (en) * | 2010-11-27 | 2012-11-29 | Cook Medical Technologies Llc | Catheters and Methods for Identification and Treatment of Bodily Passages |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
EP2677961A4 (en) | 2011-02-24 | 2014-10-29 | Eximo Medical Ltd | Hybrid catheter for vascular intervention |
JP5759615B2 (en) | 2011-04-08 | 2015-08-05 | コヴィディエン リミテッド パートナーシップ | Iontophoretic catheter system and method for renal sympathetic denervation and iontophoretic drug delivery |
EP2701623B1 (en) | 2011-04-25 | 2016-08-17 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
EP2793690B1 (en) | 2011-12-23 | 2021-04-07 | Vessix Vascular, Inc. | Expandable balloon or an electrode pad with a heat sensing device |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
EP3868321B1 (en) | 2012-06-04 | 2022-11-16 | Boston Scientific Scimed, Inc. | Systems for treating tissue of a passageway within a body |
EP2877113B1 (en) | 2012-07-24 | 2018-07-25 | Boston Scientific Scimed, Inc. | Electrodes for tissue treatment |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
KR101546153B1 (en) * | 2012-10-24 | 2015-08-26 | 포항공과대학교 산학협력단 | Squirter using ultraviolet curable polymer for aneurysm |
US9272132B2 (en) | 2012-11-02 | 2016-03-01 | Boston Scientific Scimed, Inc. | Medical device for treating airways and related methods of use |
WO2014071372A1 (en) | 2012-11-05 | 2014-05-08 | Boston Scientific Scimed, Inc. | Devices for delivering energy to body lumens |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US10842567B2 (en) | 2013-03-13 | 2020-11-24 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9456872B2 (en) * | 2013-03-13 | 2016-10-04 | The Spectranetics Corporation | Laser ablation catheter |
US10201387B2 (en) | 2013-03-13 | 2019-02-12 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
US9320530B2 (en) | 2013-03-13 | 2016-04-26 | The Spectranetics Corporation | Assisted cutting balloon |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
CN105473090B (en) | 2013-03-15 | 2019-05-03 | 波士顿科学国际有限公司 | Rebuild the method and device of the tissue of body passage or the tissue of neighbouring body passage |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9814618B2 (en) | 2013-06-06 | 2017-11-14 | Boston Scientific Scimed, Inc. | Devices for delivering energy and related methods of use |
EP3010436A1 (en) | 2013-06-21 | 2016-04-27 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
JP2016523147A (en) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal denervation balloon catheter with a riding-type electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
SG11201600014UA (en) | 2013-07-03 | 2016-02-26 | Uvlrx Therapeutics Inc | Sheathed optical fiber |
WO2015006480A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
WO2015006573A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
CN105555220B (en) | 2013-07-22 | 2019-05-17 | 波士顿科学国际有限公司 | Medical instrument for renal nerve ablation |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
CA2913220A1 (en) | 2013-08-09 | 2015-02-12 | Boston Scientific Scimed, Inc. | Expandable catheter and related methods of manufacture and use |
EP3035879A1 (en) | 2013-08-22 | 2016-06-29 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
EP3041425B1 (en) | 2013-09-04 | 2022-04-13 | Boston Scientific Scimed, Inc. | Radio frequency (rf) balloon catheter having flushing and cooling capability |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
US9861443B2 (en) | 2013-10-21 | 2018-01-09 | Carlos Bone Salat | Device for treating truncal and/or collateral varicose veins and a synergistic physio-chemical method for use |
JP2016534842A (en) | 2013-10-25 | 2016-11-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Embedded thermocouples in denervation flex circuits |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
WO2015119890A1 (en) | 2014-02-04 | 2015-08-13 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
WO2015167929A1 (en) | 2014-04-28 | 2015-11-05 | Cardiofocus, Inc. | System and method for visualizing tissue with an icg dye composition during ablation procedures |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US11877796B2 (en) | 2014-05-29 | 2024-01-23 | The Spectranetics Corporation | Material removal catheter having an expandable distal end |
US11246659B2 (en) | 2014-08-25 | 2022-02-15 | The Spectranetics Corporation | Liquid laser-induced pressure wave emitting catheter sheath |
EP3226744A4 (en) | 2014-12-03 | 2018-08-08 | Cardiofocus, Inc. | System and method for visual confirmation of pulmonary vein isolation during ablation procedures |
EP3240603B1 (en) | 2014-12-30 | 2019-05-01 | The Spectranetics Corporation | Laser-induced fluid filled balloon catheter |
WO2016109731A1 (en) | 2014-12-30 | 2016-07-07 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US11058492B2 (en) | 2014-12-30 | 2021-07-13 | The Spectranetics Corporation | Laser-induced pressure wave emitting catheter sheath |
US11344365B2 (en) | 2016-01-05 | 2022-05-31 | Cardiofocus, Inc. | Ablation system with automated sweeping ablation energy element |
CN109414292A (en) | 2016-05-05 | 2019-03-01 | 爱克斯莫医疗有限公司 | Device and method for cutting off and/or melting unwanted tissue |
USD851245S1 (en) | 2017-04-14 | 2019-06-11 | Cardiofocus, Inc. | Compliant balloon |
CN111432742B (en) | 2018-01-15 | 2024-03-01 | 卡迪奥焦点公司 | Ablation system with automatic ablation energy element |
CN113395991A (en) * | 2019-02-06 | 2021-09-14 | 纽络通医疗有限公司 | Cochlear implant and method of generating stimulation for cochlear implant |
US11179575B2 (en) | 2019-10-15 | 2021-11-23 | Cedars-Sinai Medical Center | Internal ultraviolet therapy |
US11116858B1 (en) | 2020-05-01 | 2021-09-14 | Uv Innovators, Llc | Ultraviolet (UV) light emission device employing visible light for target distance guidance, and related methods of use, particularly suited for decontamination |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0152766A1 (en) * | 1984-01-24 | 1985-08-28 | Shiley Incorporated | Reduction of an arteriosclerotic lesion by selective absorption of electromagnetic energy in a component thereof |
EP0182689A2 (en) * | 1984-10-24 | 1986-05-28 | The Beth Israel Hospital Association | Apparatus for angioplasty |
EP0311458A2 (en) * | 1987-10-08 | 1989-04-12 | The Beth Israel Hospital Association | Laser balloon catheter |
US4854315A (en) * | 1987-06-25 | 1989-08-08 | Stack Richard S | Laser catheter |
EP0341943A2 (en) * | 1988-05-09 | 1989-11-15 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Laser assisted atherectomy device and method |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4848336A (en) * | 1981-12-11 | 1989-07-18 | Fox Kenneth R | Apparatus for laser treatment of body lumens |
US4800876A (en) * | 1981-12-11 | 1989-01-31 | Fox Kenneth R | Method of and apparatus for laser treatment of body lumens |
DE3373055D1 (en) * | 1982-12-09 | 1987-09-24 | Ibm | Ablative photodecomposition of organic biological material |
US4784135A (en) * | 1982-12-09 | 1988-11-15 | International Business Machines Corporation | Far ultraviolet surgical and dental procedures |
US4784132A (en) * | 1983-03-25 | 1988-11-15 | Fox Kenneth R | Method of and apparatus for laser treatment of body lumens |
US4732148A (en) * | 1983-11-17 | 1988-03-22 | Lri L.P. | Method for performing ophthalmic laser surgery |
US4799479A (en) * | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
US4641912A (en) * | 1984-12-07 | 1987-02-10 | Tsvi Goldenberg | Excimer laser delivery system, angioscope and angioplasty system incorporating the delivery system and angioscope |
US4657014A (en) * | 1985-03-11 | 1987-04-14 | Shiley, Inc. | Liquid interface fiberoptic coupler |
US4862886A (en) * | 1985-05-08 | 1989-09-05 | Summit Technology Inc. | Laser angioplasty |
US4754752A (en) * | 1986-07-28 | 1988-07-05 | Robert Ginsburg | Vascular catheter |
AU3696989A (en) * | 1988-05-18 | 1989-12-12 | Kasevich Associates, Inc. | Microwave balloon angioplasty |
EP0360582A3 (en) * | 1988-09-23 | 1991-08-14 | Trimedyne Laser Systems, Inc. | Heated catheter with thermal barrier |
-
1990
- 1990-10-10 US US07/595,033 patent/US5053033A/en not_active Expired - Fee Related
-
1991
- 1991-09-04 JP JP3516153A patent/JPH06501859A/en active Pending
- 1991-09-04 WO PCT/US1991/006313 patent/WO1992006741A2/en active IP Right Grant
- 1991-09-04 AT AT94110276T patent/ATE168546T1/en not_active IP Right Cessation
- 1991-09-04 ES ES94110276T patent/ES2121592T3/en not_active Expired - Lifetime
- 1991-09-04 DE DE69108041T patent/DE69108041T2/en not_active Expired - Fee Related
- 1991-09-04 EP EP91917175A patent/EP0552189B1/en not_active Expired - Lifetime
- 1991-09-04 AU AU85464/91A patent/AU655939B2/en not_active Ceased
- 1991-09-04 CA CA002092537A patent/CA2092537A1/en not_active Abandoned
- 1991-09-04 EP EP94110276A patent/EP0629380B1/en not_active Expired - Lifetime
- 1991-09-04 AT AT91917175T patent/ATE119403T1/en not_active IP Right Cessation
- 1991-09-04 DE DE69129864T patent/DE69129864T2/en not_active Expired - Fee Related
- 1991-09-04 ES ES91917175T patent/ES2073172T3/en not_active Expired - Lifetime
-
1995
- 1995-04-19 AU AU16559/95A patent/AU669833B2/en not_active Ceased
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0152766A1 (en) * | 1984-01-24 | 1985-08-28 | Shiley Incorporated | Reduction of an arteriosclerotic lesion by selective absorption of electromagnetic energy in a component thereof |
EP0182689A2 (en) * | 1984-10-24 | 1986-05-28 | The Beth Israel Hospital Association | Apparatus for angioplasty |
US4854315A (en) * | 1987-06-25 | 1989-08-08 | Stack Richard S | Laser catheter |
EP0311458A2 (en) * | 1987-10-08 | 1989-04-12 | The Beth Israel Hospital Association | Laser balloon catheter |
EP0341943A2 (en) * | 1988-05-09 | 1989-11-15 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Laser assisted atherectomy device and method |
Non-Patent Citations (1)
Title |
---|
Color Research and Application, vol. 9, no. 4, 1984, (New York, US), P.K. KAISER: "Phototherapy using chromatic, white, and ultraviolet light", pages 195-205 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8109981B2 (en) | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
Also Published As
Publication number | Publication date |
---|---|
AU8546491A (en) | 1992-05-20 |
JPH06501859A (en) | 1994-03-03 |
EP0629380A1 (en) | 1994-12-21 |
ES2073172T3 (en) | 1995-08-01 |
AU1655995A (en) | 1995-08-03 |
EP0552189B1 (en) | 1995-03-08 |
US5053033A (en) | 1991-10-01 |
ATE119403T1 (en) | 1995-03-15 |
DE69129864D1 (en) | 1998-08-27 |
EP0629380B1 (en) | 1998-07-22 |
ATE168546T1 (en) | 1998-08-15 |
DE69129864T2 (en) | 1999-04-15 |
ES2121592T3 (en) | 1998-12-01 |
DE69108041T2 (en) | 1995-10-19 |
EP0552189A1 (en) | 1993-07-28 |
AU655939B2 (en) | 1995-01-19 |
WO1992006741A3 (en) | 1992-08-20 |
DE69108041D1 (en) | 1995-04-13 |
CA2092537A1 (en) | 1992-04-11 |
AU669833B2 (en) | 1996-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0552189B1 (en) | Inhibition of restenosis by ultraviolet radiation | |
US5776174A (en) | Stabilization of vascular lesions by ultraviolet radiation | |
US4862886A (en) | Laser angioplasty | |
US6520957B1 (en) | Treatment of in-stent restenosis using cytotoxic radiation | |
US10653482B2 (en) | System for vaporization of tissue | |
AU580575B2 (en) | Medical treatment using an excimer laser | |
US20190307508A1 (en) | Laser treatment of benign prostatic hypertrophy | |
WO1988007841A1 (en) | Method and apparatus for laser angiosurgery | |
US20210220051A1 (en) | Laser treatment of the prostate | |
ROSIN et al. | A review of technical and clinical aspects of biliary laser lithotripsy | |
WO2024017288A1 (en) | Vascular repair system and control method | |
Litvack et al. | Laser angioplasty: status and prospects | |
CN117462241A (en) | Vascular repair system and control method | |
Arai et al. | Continuous wave laser angioplasty using IR (CO) or UV (Ar) lasers under visualization by a thin endoscope: in-vitro and in-vivo animal experiments | |
Daidoh et al. | Basic investigation of laser therapy for the ureteral stricture using ultraviolet argon laser and multifiber catheter | |
Geschwind et al. | Recanalization of human arteries using Nd-YAG laser carried by optical fibre | |
Stančk et al. | Pulsed Nd: YAG-Laser Angioplasty of Peripheral Arteries—Experiments in Cadavers | |
Fracasso et al. | Coronary laser angioplasty | |
Repacholi et al. | Current and Future Applications of Lasers in Medicine | |
Harris | Future trends in the medical laser industry | |
McCowan et al. | Angioscopic monitoring of in vivo laser angioplasty | |
Bown | Medical Lasers-Their Clinical Role And The Methods Of Power Delivery | |
Fracasso et al. | UV Laser Angioplasty: Clinical Aspects | |
Manenkov et al. | Potentials for pulsed YAG: Nd laser application to endoscopic surgery | |
Iwasaki et al. | Fundamental Research in Laser Angioplasty (1): Effects of Nd: YAG, Argon-Ion and Excimer Lasers on Human Aortic Wall with or Without Atheromatous Plaque |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP KR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP KR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991917175 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2093537 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1991917175 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1991917175 Country of ref document: EP |